Literature DB >> 6338042

Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.

A H Kissebah, S Alfarsi, D J Evans, P W Adams.   

Abstract

Plasma low density lipoprotein (LDL) transport kinetics were determined from the disappearance of 125I-LDL injected into age- and weight-matched groups of 13 normal subjects, 20 mild diabetics, and 8 moderately severe diabetic patients (fasting plasma glucose less than 150 and greater than 150 mg/100 ml, respectively). In mild diabetics, LDL apo-lipoprotein-B (apo-B) synthetic rate (SR) was significantly greater than normal. The fractional catabolic rate (FCR), however, was also increased so that plasma LDL concentration remained normal. In moderately severe diabetics, LDL SR was normal but FCR was reduced resulting in increased plasma LDL cholesterol and apo-B concentrations. In normal subjects, moderate obesity was associated with increased LDL secretion. In diabetic subjects, however, changes in LDL turnover were of equal magnitude in obese and nonobese patients. In normolipemic and hyperlipemic mild diabetic subjects with equal degrees of glucose intolerance, both LDL apo-B SR and FCR were greater than normal. The magnitude of these increases, however, was lower in the hyperlipemic individuals. Stepwise regression analysis revealed that both LDL SR and FCR correlated positively and linearly with insulin response to glucose loading, but negatively and curvilinearly with fasting plasma glucose and glucose response. We propose that in noninsulin-dependent diabetes, mild hyperglycemia is accompanied by increased LDL turnover, despite normal plasma LDL levels, whereas moderately severe hyperglycemia is associated with decreased LDL catabolism, resulting in increased plasma LDL levels. These changes cannot be attributed to the presence of obesity or hypertriglyceridemia, and may relate to varying degrees of insulin resistance and decreased insulin secretion affecting plasma very low density lipoprotein (VLDL) secretion, VLDL conversion to LDL, and LDL catabolism. Both increased LDL turnover in mild diabetes and delayed removal of LDL in moderately severe diabetes could increase cholesterol ester availability to peripheral tissues, and may result in an increased risk of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338042      PMCID: PMC436915          DOI: 10.1172/jci110812

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts.

Authors:  A Chait; E L Bierman; J J Albers
Journal:  Biochim Biophys Acta       Date:  1978-05-25

2.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

3.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

Review 4.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

5.  The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism.

Authors:  P W Adams; A H Kissebah; P Harrigan; T Stokes; V Wynn
Journal:  Eur J Clin Invest       Date:  1974-06       Impact factor: 4.686

6.  Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level.

Authors:  R J Santen; P W Willis; S S Fajans
Journal:  Arch Intern Med       Date:  1972-12

7.  Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity.

Authors:  J L Witztum; E M Mahoney; M J Branks; M Fisher; R Elam; D Steinberg
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

8.  Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man.

Authors:  A H Kissebah; S Alfarsi; P W Adams; V Wynn
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

9.  Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia.

Authors:  E D Janus; A Nicoll; R Wootton; P R Turner; P J Magill; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

10.  Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects.

Authors:  M B Mattock; J H Fuller; P S Maude; H Keen
Journal:  Atherosclerosis       Date:  1979-12       Impact factor: 5.162

View more
  13 in total

1.  Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice.

Authors:  Ding Ai; Chiyuan Chen; Seongah Han; Anjali Ganda; Andrew J Murphy; Rebecca Haeusler; Edward Thorp; Domenico Accili; Jay D Horton; Alan R Tall
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

2.  Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus.

Authors:  W Kortlandt; C Benschop; H J van Rijn; D W Erkelens
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

3.  Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study.

Authors:  M Laakso; M Suhonen; R Julkunen; K Pyörälä
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

4.  Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Mary E Gearing; Alisha V Ling; Kathryn A Williams; Ji Miao; Stuart S Adamson; Dong-Ju Shin; Satyapal Chahar; Mark J Graham; Rosanne M Crooke; Lee R Hagey; David Vicent; Sarah D de Ferranti; Srividya Kidambi; Clary B Clish; Sudha B Biddinger
Journal:  Circulation       Date:  2022-02-23       Impact factor: 39.918

5.  Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man.

Authors:  H Yki-Järvinen; M R Taskinen; V A Koivisto; E A Nikkilä
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

6.  Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.

Authors:  P Ebeling; V A Koivisto
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

Review 7.  The regulation of ApoB metabolism by insulin.

Authors:  Mary E Haas; Alan D Attie; Sudha B Biddinger
Journal:  Trends Endocrinol Metab       Date:  2013-05-27       Impact factor: 12.015

8.  Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.

Authors:  Nicholas Stoycheff; Lesley A Stevens; Christopher H Schmid; Hocine Tighiouart; Julia Lewis; Robert C Atkins; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2009-06-25       Impact factor: 8.860

9.  Removal from the plasma of the free and esterified forms of cholesterol and transfer of lipids to HDL in type 2 diabetes mellitus patients.

Authors:  Carolina P Oliveira; Raul C Maranhão; Marina P Bertato; Bernardo L Wajchenberg; Antonio C Lerario
Journal:  Lipids Health Dis       Date:  2012-06-07       Impact factor: 3.876

10.  Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.

Authors:  Alina C R Feitosa; Gilson S Feitosa-Filho; Fatima R Freitas; Bernardo L Wajchenberg; Raul C Maranhão
Journal:  Lipids Health Dis       Date:  2013-02-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.